V Zucconi, M T Bolaffio. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » Acute DiseaseAdrenergic alpha-Antagonists/administration & dosageAdrenergic alpha-Antagonists/pharmacologyAdrenergic alpha-Antagonists/therapeutic useAgedDrug EvaluationErgolines/administration & dosageErgolines/pharmacologyErgolines/therapeutic useErgoloid Mesylates/administration & dosageErgoloid Mesylates/pharmacologyErgoloid Mesylates/therapeutic useFemaleHemiplegia/drug therapyHumansIntelligence/drug effectsMaleMiddle AgedMotor Skills/drug effectsNicotinic Acids/administration & dosageNicotinic Acids/pharmacologyNicotinic Acids/therapeutic useTime Factors
Substances: See more » Adrenergic alpha-AntagonistsErgolinesNicotinic AcidsErgoloid Mesylates
Year: 1974 PMID: 4151126
Source DB: PubMed Journal: Minerva Med ISSN: 0026-4806 Impact factor: 4.806